Skip to content

Clinical trials

Osteoporosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Clear all

1,553 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200023
200130
200228
200351
200457
200552
200681
200768
200869
200963
201059
201152
201270
201361
201449
201558
201642
201752
201851
201956
202044
202159
202252
202376
202468
202558
202653

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,025
Unknown status214
Recruiting101
Terminated66
Active, not recruiting44
Not yet recruiting44
Withdrawn43
Enrolling by invitation12
Suspended4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen32
National Taiwan University Hospital32
Eli Lilly and Company23
Merck Sharp & Dohme LLC21
GlaxoSmithKline19
Novartis Pharmaceuticals19
Massachusetts General Hospital16
University of Aarhus15
University of Alabama at Birmingham14
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)12

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis1,553
Bone Diseases, Metabolic267
Osteoporosis, Postmenopausal125
Fractures, Bone120
Sarcopenia63
Osteoporotic Fractures50
Diabetes Mellitus49
Hip Fractures49
Breast Neoplasms45
Spinal Fractures44

Trials

Showing 76 to 100 of 1,553. Each trial links to its page on Pharma Observatory.

1,453 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.